Moran Kyle's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Dec 10, 2025
- Accession no.
- 0001193125-25-314736
- Filed
- Dec 10, 2025
- Trade date
- Dec 8-9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 11 non-derivative transactions and 5 derivative transactions. Open-market sales total $4.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moran KyleCIK 0001657765 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Ordinary Shares | MOption exerciseAcquired | +60,000 | $2.83 | +$169,800 | 149,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −60,000 | $13.20 | −$792,000 | 89,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | MOption exerciseAcquired | +100,000 | $3.14 | +$314,000 | 189,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −50,000 | $15.00 | −$750,000 | 139,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −50,000 | $13.20 | −$660,000 | 89,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | MOption exerciseAcquired | +50,000 | $4.75 | +$237,500 | 139,218 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −50,000 | $18.00 | −$900,000 | 89,218 | Direct | |
| Dec 9, 2025 | Ordinary Shares | MOption exerciseAcquired | +36,000 | $8.17 | +$294,120 | 125,218 | Direct | |
| Dec 9, 2025 | Ordinary Shares | SSaleDisposed | −36 | $20.25 | −$729 | 89,218 | Direct | |
| Dec 9, 2025 | Ordinary Shares | MOption exerciseAcquired | +50,000 | $10.48 | +$524,000 | 139,218 | Direct | |
| Dec 9, 2025 | Ordinary Shares | SSaleDisposed | −50,000 | $20.03 | −$1,001,500 | 90,365 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Ordinary Shares | AGrant or awardDisposed | −60,000 | $0.00 | $0 | 0 | Direct | |
| Dec 8, 2025 | Ordinary Shares | AGrant or awardDisposed | −100,000 | $0.00 | $0 | 75,000 | Direct | |
| Dec 8, 2025 | Ordinary Shares | AGrant or awardDisposed | −50,000 | $0.00 | $0 | 222,700 | Direct | |
| Dec 9, 2025 | Ordinary Shares | AGrant or awardDisposed | −36,000 | $0.00 | $0 | 0 | Direct | |
| Dec 9, 2025 | Ordinary Shares | AGrant or awardDisposed | −50,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.